July 24, 2018
AdvaMed Statement on House Passage of Device Tax Repeal
WASHINGTON, D.C. -The Advanced Medical Technology Association (AdvaMed)issued the following statement from President and CEO Scott Whitaker after passage in the U.S. House of legislation to permanently repeal the medical device excise tax:
"Today's vote is a win for American innovation, American jobs, and most of all for American patients, who benefit from the life-changing innovations our industry produces every day. We commend Rep. Erik Paulsen (R-Minn.) and a number of leaders from both sides of the aisle for their commitment to permanently repealing this onerous tax and for working to ensure our member companies have the long-term certainty they need to invest in R&D, hiring and other capital improvements to create the next-generation of treatments and cures.
"The overwhelming, bipartisan support for repeal sends a strong message that lawmakers recognize this tax is not good health policy or good fiscal policy. We know a significant majority of the Senate feels the same way andurge themto quickly take up this measure and eliminate once and for all this drag on one of the country's best hopes for better patient care and economic growth."
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visitwww.advamed.org.
Mark E. Brager
Vice President, Communications